The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

Aalto University scientists have created a laser-based treatment that uses gentle heat to stop the progression of dry macular ...

The clinical trial enrolled 38 adults aged 60 and older who had advanced geographic atrophy, the late stage of macular ...

In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degen ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...

A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

Age-related macular degeneration (AMD) causes progressive vision loss in a large number of elderly people, and no treatment ...

The nods allow Regeneron to better compete with Roche, which stormed the market in 2022 with Vabysmo. The Swiss drugmaker's ...

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...